ArticleCase reports in hematology2017

Sequential Use of Second-Generation Tyrosine Kinase Inhibitor Treatment and Intensive Chemotherapy Induced Long-Term Complete Molecular Response in Imatinib-Resistant CML Patient Presenting as a Myeloid Blast Crisis.

Masaaki Tsuji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.